Altius puts control in your hands, delivering treatment at the press of a button.

IT'S TIME TO TAKE BACK CONTROL

Take the survey to find out if you might qualify

Take the survey to learn more about Altius, a non-drug treatment for chronic, unmanaged Post-Amputation Pain.

This animation shows how the Altius system targets the source of chronic Post-Amputation Pain.

- The Altius system uses electrical pulses to target pain at the source.

- Electrodes are wrapped around the affected nerve, and a rechargeable implant sends the electrical pulses.

- Patients control the device with a wireless remote for on-demand pain relief.

50% Reduction in pain.*

In a clinical study¹ that followed patients through 12 months, patients treated with the Altius System reported*:

Pain Reduction

-30% less pain in just 30 minutes

-50% reduction in pain in 120 minutes

-50% fewer days with moderate or severe pain

* Patients in the clinical study started therapy with Altius upon feeling pain. Patients averaged ~30% reduction in pain 30 minutes after starting a session and ~50% reduction in pain 120 minutes after starting a session. Days with pain was defined as pain greater than or equal to 4 on a pain intensity scale of 0 to 10. When asked to rate how pain interfered with daily activities on a scale 0-10, patients in the study reported 44% improvement in walking and 48% improvement in relationships after Altius.

This surgery might be right for you if: 

- You have a Lower Limb Amputation 

- You suffer with chronic Post-Amputation Pain

- You are over the age of 21

- Your pain is unmanageable with your current pain treatments

Take the survey to see if this procedure may be an option for you

This survey is not a substitute for professional medical advice, and is not intended to provide a medical diagnosis. Consult your doctor

Phantom limb pain, residual limb pain, or both

Below and above the knee amputations

Disease-related and trauma-related amputations

Continuous or intermittent pain

Not all patients will experience similar results.

1. Kapural L, Kim B, Eidt J, et al. Long-term treatment of chronic post-amputation pain with bioelectric nerve block:

Clinical trial for phantom limb pain - 12-month results of the randomized, doubled-blinded, crossed-over QUEST study. Neuromodulation. 2024. 180 patients were enrolled in the clinical study. Individual patient outcomes may vary.

Indications for Use: The Altius® Direct Electrical Nerve Stimulation System is indicated as an aid in the management of chronic intractable phantom and residual lower limb post-amputation pain in adult amputees. Contraindications: The Altius system is contraindicated for patients who are: Unable to operate the system or Unsuitable for the Altius implant surgery. Warnings/Precautions: Use as indicated and instructed. Diathermy should not be used on patients with the Altius System, or any of its components, either as a treatment for a medical condition or as part of a surgical procedure. Electromagnetic interference (EMI) is a field of energy generated by equipment found in the home, work, medical, or public environments that is strong enough to interfere with Altius system function. The electrical pulses from the Altius system may interact with the sensing operation from a cardiac device and could result in an inappropriate response of the cardiac device; physicians involved should discuss the possible interactions between the devices before surgery. Safety and Effectiveness of Altius System for pediatric use and for pregnant patients has not been established. Surgical complications and adverse events may be more frequent and severe in diabetic patients. Safety of MRI/NMRI with an implanted Altius system has not been evaluated. Patients implanted with the Altius System, or any of its components, should not be subject to MRI/NMRI. See Instructions for Use for detailed information regarding the procedure(s), indications, contraindications, warnings, precautions, and potential adverse events. For further information and to view full Instructions for Use, visit www.neurosmedical.com.

Rx Only

Although FDA has determined that the probable benefits outweigh the probable risks, there remains some uncertainty regarding the manufacturer’s human factors engineering (HFE) and usability engineering (UE) analysis and validation testing. As a condition of approval, FDA is requiring the manufacturer to provide an HFE/UE analysis and validation testing and recommending that this analysis and testing is designed using the FDA’s 2016 guidance document “Applying Human Factors and Usability Engineering to Medical Devices” (https://www.fda.gov/media/80481/download).

This information is for informational purposes only, is not medical advice or a diagnosis, and is not a substitute for professional medical advice. Consult with your doctor regarding your condition. Individual symptoms, circumstances, and results vary.

© 2025 83bar   /

 /  Rx Only

Privacy Policy

LB-0251 Rev C